{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:39:15Z","timestamp":1789879155932,"version":"4.0.1"},"reference-count":27,"publisher":"Portland Press Ltd.","issue":"6","license":[{"start":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T00:00:00Z","timestamp":1564099200000},"content-version":"vor","delay-in-days":217,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,12,21]]},"abstract":"<jats:p>One of the treatment failures for colorectal cancer (CRC) is resistance to chemotherapy drugs. miRNAs have been demonstrated to be a new regulator of pathobiological processes in various tumors. While few studies have explored the specific role of miR-141 in mediating 5-fluorouracil (5-FU) sensitivity of CRC cells, the present study aimed to detect the contribution of miR-141 in 5-FU sensitivity. The CRC cells viability was measured by MTS assay and cell colony forming. The expression of miR-141 and its downstream targets were assessed by reverse transcription quantitative PCR, Western blotting, and immunohistochemistry. The functional assays were conducted using CRC cells and nude mice. At the present study, we found overexpression of miR-141 could inhibit proliferation, migration, tumor-forming and invasive potential of CRC cells in vitro and mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4) was verified as a directed target of miR-141. The combination treatment of miR-141 with 5-FU, directly targetting MAP4K4, could better inhibit invasion and metastasis of CRC cells colony than either one alone. Furthermore, overexpression of miR-141, targetting MAP4K4, enhanced the effected of 5-FU and suppressed the malignant biological behaviors, in vivo. Our findings showed that 5-FU inhibited malignant behavior of human CRC cells in vitro and in vivo by enhancing the efficiency of miR-141. Our data suggested that targetting the miR-141\/MAP4K4 signaling pathway could be a potential molecular target that may enhance chemotherapeutic efficacy in the treatment of CRC.<\/jats:p>","DOI":"10.1042\/bsr20180978","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T17:36:30Z","timestamp":1542216990000},"update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Chemotherapy-induced <i>miR-141<\/i>\/MAP4K4 signaling suppresses progression of colorectal cancer"],"prefix":"10.1042","volume":"38","author":[{"given":"Feifei","family":"Wang","sequence":"first","affiliation":[{"name":"Department of the Second General Surgery, The Fourth Hospital, Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianmei","family":"Zhao","sequence":"additional","affiliation":[{"name":"Research Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of the Second General Surgery, The Fourth Hospital, Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zesong","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of the Second General Surgery, The Fourth Hospital, Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoxi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of the Second General Surgery, The Fourth Hospital, Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanglin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of the Second General Surgery, The Fourth Hospital, Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youqiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of the Second General Surgery, The Fourth Hospital, Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[{"name":"Pediatric Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinchuan","family":"Xi","sequence":"additional","affiliation":[{"name":"Department of the Second General Surgery, The Fourth Hospital, Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of the Second General Surgery, The Fourth Hospital, Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6415-818X","authenticated-orcid":false,"given":"Guiying","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of the Second General Surgery, The Fourth Hospital, Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2018,12,21]]},"reference":[{"key":"2021111619201935500_B1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China","volume":"66","author":"Chen","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"2021111619201935500_B2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"2021111619201935500_B3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"2021111619201935500_B4","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/nrg2634","article-title":"Causes and consequences of microRNA dysregulation in cancer","volume":"10","author":"Croce","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"2021111619201935500_B5","doi-asserted-by":"publisher","first-page":"R762","DOI":"10.1016\/j.cub.2014.06.043","article-title":"Aberrant regulation and function of microRNAs in cancer","volume":"24","author":"Adams","year":"2014","journal-title":"Curr. Biol."},{"key":"2021111619201935500_B6","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.3892\/etm.2016.3751","article-title":"Role of microRNA-141 in colorectal cancer with lymph node metastasis","volume":"12","author":"Feng","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"2021111619201935500_B7","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1128\/MCB.23.6.2068-2082.2003","article-title":"The STE20 kinase HGK is broadly expressed in human tumour cells and can modulate cellular transformation, invasion, and adhesion","volume":"23","author":"Wright","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"2021111619201935500_B8","doi-asserted-by":"publisher","first-page":"7043","DOI":"10.1158\/1078-0432.CCR-08-0381","article-title":"Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma","volume":"14","author":"Liang","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"2021111619201935500_B9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nature14323","article-title":"MAP4K4 regulates integrin-FERM binding to control endothelial cell motility","volume":"519","author":"Vitorino","year":"2015","journal-title":"Nature"},{"key":"2021111619201935500_B10","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1073\/pnas.0600040103","article-title":"A small interfering RNA screen for modulators of tumour cell motility identifies MAP4K4 as a promigratory kinase","volume":"103","author":"Collins","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111619201935500_B11","doi-asserted-by":"publisher","first-page":"122","DOI":"10.7150\/ijbs.14770","article-title":"miR-15a-3p and miR-16-1-3p negatively regulate twist1 to repress gastric cancer cell invasion and metastasis","volume":"13","author":"Wang","year":"2017","journal-title":"Int. J. Biol. Sci."},{"key":"2021111619201935500_B12","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1158\/0008-5472.CAN-04-2749","article-title":"Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice","volume":"65","author":"Shi","year":"2005","journal-title":"Cancer Res."},{"key":"2021111619201935500_B13","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1159\/000445555","article-title":"Periplocin extracted from cortex periplocae induced apoptosis of gastric cancer cells via the ERK1\/2-EGR1 pathway","volume":"38","author":"Li","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"2021111619201935500_B14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11523-013-0281-x","article-title":"Role of targeted agents in metastatic colorectal cancer","volume":"8","author":"Prenen","year":"2013","journal-title":"Targ. Oncol."},{"key":"2021111619201935500_B15","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.2147\/OTT.S90012","article-title":"miR-21 inhibits the effects of cyclooxygenase-2 inhibitor NS398 on apoptosis and invasion in gastric cancer cells","volume":"8","author":"Li","year":"2015","journal-title":"Onco. Targets Ther."},{"key":"2021111619201935500_B16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11010-016-2816-9","article-title":"Involvement of microRNA-141-3p in 5-fluorouracil and oxaliplatin chemo-resistance in esophageal cancer cells via regulation of PTEN","volume":"422","author":"Jin","year":"2016","journal-title":"Mol. Cell. Biochem."},{"key":"2021111619201935500_B17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1248\/bpb.b14-00695","article-title":"Induction of epithelial-mesenchymal transition and down-regulation of miR-200c and miR-141 in oxaliplatin-resistant colorectal cancer cells","volume":"38","author":"Tanaka","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"2021111619201935500_B18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3892\/or.2016.5259","article-title":"miR-20b reduces 5-FU resistance by suppressing the ADAM9\/EGFR signaling pathway in colon cancer","volume":"37","author":"Fu","year":"2017","journal-title":"Oncol. Rep."},{"key":"2021111619201935500_B19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev-pathol-012513-104715","article-title":"microRNAs in cancer","volume":"9","author":"Di Leva","year":"2014","journal-title":"Annu. Rev. Pathol."},{"key":"2021111619201935500_B20","doi-asserted-by":"publisher","first-page":"14270","DOI":"10.1038\/ncomms14270","article-title":"microRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"key":"2021111619201935500_B21","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1007\/s10620-015-3782-x","article-title":"miR-141 inhibits gastric cancer proliferation by interacting with long noncoding RNA MEG3 and down-regulating E2F3 expression","volume":"60","author":"Zhou","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"2021111619201935500_B22","first-page":"4345","article-title":"miR-141 inhibits proliferation and migration of colorectal cancer SW480 cells","volume":"37","author":"Long","year":"2017","journal-title":"Anticancer Res."},{"key":"2021111619201935500_B23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41419-018-0399-y","article-title":"ELF3 promotes epithelial-mesenchymal transition by protecting ZEB1 from miR-141-3p-mediated silencing in hepatocellular carcinoma","volume":"9","author":"Zheng","year":"2018","journal-title":"Cell Death Dis."},{"key":"2021111619201935500_B24","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/1878-0261.12055","article-title":"MAP4K4 is a novel MAPK\/ERK pathway regulator required for lung adenocarcinoma maintenance","volume":"11","author":"Gao","year":"2017","journal-title":"Mol. Oncol."},{"key":"2021111619201935500_B25","doi-asserted-by":"publisher","first-page":"11457","DOI":"10.1007\/s13277-016-5022-1","article-title":"MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma","volume":"37","author":"Feng","year":"2016","journal-title":"Tumour Biol."},{"key":"2021111619201935500_B26","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1369\/0022155415590829","article-title":"Silencing SOX2 expression by rna interference inhibits proliferation, invasion and metastasis, and induces apoptosis through MAP4K4\/JNK signaling pathway in human laryngeal cancer TU212 cells","volume":"63","author":"Yang","year":"2015","journal-title":"J. Histochem. Cytochem."},{"key":"2021111619201935500_B27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3892\/mmr.2015.4510","article-title":"Silencing of MAP4K4 by short hairpin RNA suppresses proliferation, induces G1 cell cycle arrest and induces apoptosis in gastric cancer cells","volume":"13","author":"Liu","year":"2015","journal-title":"Mol. Med. Rep."}],"container-title":["Bioscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20180978\/809324\/bsr-2018-0978.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20180978\/809324\/bsr-2018-0978.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T20:15:46Z","timestamp":1637093746000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/bioscirep\/article\/38\/6\/BSR20180978\/98177\/Chemotherapy-induced-miR-141-MAP4K4-signaling"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,21]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12,21]]}},"URL":"https:\/\/doi.org\/10.1042\/bsr20180978","relation":{},"ISSN":["0144-8463","1573-4935"],"issn-type":[{"value":"0144-8463","type":"print"},{"value":"1573-4935","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,21]]},"article-number":"BSR20180978"}}